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Abstract
Background: Anti-viral CD8 T-cell activity is enhanced and prolonged by CD4 T-cell-mediated help, but negatively
regulated by inhibitory B7-H1 interactions. During viral encephalomyelitis, the absence of CD4 T cells decreases CD8
T cell activity and impedes viral control in the central nervous system (CNS). By contrast, the absence of B7-H1
enhances CD8 T-cell function and accelerates viral control, but increases morbidity. However, the relative
contribution of CD4 T cells to CD8 function in the CNS, in the absence of B7-H1, remains unclear.
Methods: Wild-type (WT) and B7-H1−/− mice were infected with a gliatropic coronavirus and CD4 T cells depleted
to specifically block T helper function in the CNS. Flow cytometry and gene expression analysis of purified T-cell
populations from lymph nodes and the CNS was used to directly monitor ex vivo T-cell effector function. The
biological affects of altered T-cell responses were evaluated by analysis of viral control and spinal-cord pathology.
Results: Increased anti-viral activity by CD8 T cells in the CNS of B7-H1−/− mice was lost upon depletion of CD4 T cells;
however, despite concomitant loss of viral control, the clinical disease was less severe. CD4 depletion in B7-H1−/− mice
also decreased inducible nitric oxide synthase expression by microglia and macrophages, consistent with decreased
microglia/macrophage activation and reduced interferon (IFN)-γ. Enhanced production of IFN-γ, interleukin (IL)-10 and
IL-21 mRNA was seen in CD4 T cells from infected B7-H1−/− compared with WT mice, suggesting that over-activated
CD4 T cells primarily contribute to the increased pathology.
Conclusions: The local requirement of CD4 T-cell help for CD8 T-cell function is not overcome if B7-H1 inhibitory signals
are lost. Moreover, the increased effector activity by CD8 T cells in the CNS of B7-H1−/− mice is attributable not only to
the absence of B7-H1 upregulation on major histocompatibility complex class I-presenting resident target cells, but also
to enhanced local CD4 T-cell function. B7-H1-mediated restraint of CD4 T-cell activity is thus crucial to dampen both
CD8 T-cell function and microglia/macrophage activation, thereby providing protection from T-cell-mediated bystander
damage.
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Background
The magnitude, quality and longevity of CD8 T-cell ef-
fector function is positively regulated by CD4 T cells, and
negatively regulated by various T-cell inhibitory molecules.
CD4 T cells augment CD8 T-cell activation and expansion,
directly through the production of cytokines or indirectly
by licensing dendritic cells (DCs) in draining lymph nodes
[1,2]. Moreover, CD4 T cells can further enhance the pri-
mary anti-viral responses of CD8 T cells and promote their
survival in the target organ [3-8]. This function is especially
crucial in sustaining CD8 T-cell activity during prolonged
and chronic infections. Paradoxically however, both CD4
and CD8 T cells upregulate numerous inhibitory molecules
upon extended exposure to antigen to counterbalance
over-exuberant, and potentially damaging, T-cell activity.
Negative regulation by T-cell engagement of inhibitory
ligands allows customized fine-tuning of T-cell function
and mobility by the respective antigen-presenting cells
(APCs) in the local environment. Among the compo-
nents regulating the delicate balance between protective
and detrimental immunity is programmed death (PD)-1,
which dampens T-cell proliferation, cytokine production,
and cytolytic activity following interaction with its ligand
B7-H1.
The ongoing regulation of T cells and their adaptation
to the local environment is most apparent during persist-
ent infections, when CD4 T cells are essential to prolong
CD8 T-cell function and survival [9-11]; however interac-
tions between inhibitory receptors and their ligands
dampen anti-viral function [11-15]. This paradigm also
applies to encephalomyelitis induced by the sub-lethal
gliatropic JHM strain of mouse hepatitis virus (JHMV).
In this model, T cells control acute virus replication using
both perforin-mediated and interferon (IFN)-γ-mediated
mechanisms [16-19]; however, CD8 T-cell function rap-
idly wanes, allowing persistent infection [20]. Further-
more, T-cell activity is associated with immune-mediated
demyelination, which is sustained throughout the viral
persistence [21]. CD8 T cells are primary adaptive anti-
viral effectors, but CD4 T cells play a vital supportive
role, and may also directly contribute to viral control
[8,16-19]. Depletion of CD4 T cells at distinct times rela-
tive to infection showed that CD4 T cells not only en-
hance peripheral CD8 T-cell priming/expansion, but
further promote CD8 T-cell function locally within the
central nervous system (CNS) [8]. CD8 T cells deprived
of CD4 T-cell help within the CNS (designated ‘unhelped’
CD8 Tcells), have diminished effector function and are un-
able to control virus replication [8]. Recent analysis of the
contribution of inhibitory interactions during JHMV
pathogenesis further showed that virus-specific CD8 T cells
in the CNS express high levels of PD-1 [22]. Moreover,
oligodendroglia, which are prominent targets of infection,
strongly upregulate the ligand B7-H1 in response to IFN-γ
during infection [22]. In a previous study, the dampening
effects of PD-1:B7-H1 interaction were evident by
increased IFN-γ and granzyme B production by CNS-
infiltrating CD8 T cells, coincident with accelerated virus
control and decreased viral persistence in JHMV-infected
B7-H1 deficient (B7-H1−/−) mice [15]. Conversely, how-
ever, the extent of axonal damage was exacerbated, sug-
gesting that B7-H1 mediates protection from immune
pathology and mortality [15]. Oligodendrocytes were
shown to upregulate major histocompatibility complex
(MHC) class I, but not MHC class II during JHMV infec-
tion [23], thus the improved viral control was attributed
to enhanced CD8 T-cell activity. However, demyelination
was similar to infected wild-type (WT) mice [23], sug-
gesting that the absence of B7-H1 did not overtly in-
crease the vulnerability of oligodendrocytes to immune
attack. This conundrum led us to explore the possible
contribution of CD4 T cells to enhanced viral control
and pathology, especially as CD4 T cells are potent pro-
ducers of IFN-γ in vivo, and are strongly associated with
pathogenicity and clinical disease [4,24].
The current study characterizes the relative contribu-
tions of CD4 T-cell help and B7-H1 to CD8 T-cell effector
function in the CNS during viral encephalomyelitis by
addressing three interrelated questions. 1) Is enhanced
CD8 effector T-cell activity and viral control in B7-H1−/−
mice dependent on local CD4 T cells, similar to WT mice?
2) Is CNS CD4 T-cell function dampened by B7-H1? 3) Is
increased axonal damage in the absence of B7-H1 sus-
tained in the absence of CD4 T cells? To ensure presence
of CD4 T-cell help during priming but withdrawal of
helper function within the CNS, CD4 T cells were depleted
in B7-H1−/− mice subsequent to the initial expansion
phase, but before CNS entry [8]. Numbers and compos-
ition of CNS-infiltrating cells were comparable in CD4-
depleted mice; however, decreased granzyme B and IFN-γ
expression by CD8 T cells correlated with loss of viral con-
trol. Moreover increased CD8 function was associated with
increased CD4 T-cell activity in B7-H1−/− mice. The ab-
sence of CD4 T cells in B7-H1−/− mice did not affect de-
myelination or significantly lessen axonal damage, but did
improve clinical disease and survival.
Methods
Ethics approval
All procedures were conducted in accordance with ani-
mal protocols approved by the Institutional Animal Care
and Use Committee.
Mice, virus infection, and CD4 depletion
The WT mouse strain was C57BL/6 (National Cancer
Institute (Frederick, MD, USA). B7-H1−/− mice on a
C57BL/6 background were previously described [25].
Mice were housed under pathogen-free conditions at an
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accredited facility in the Cleveland Clinic Lerner Re-
search Institute. Mice were infected at 6–7 weeks of age
by intracranial injection with 250 plaque-forming units
(PFUs) of the gliatropic JHM variant V2.2-1 of mouse
hepatitis virus (JHMV) [26]. Recipient animals were
depleted of CD4 T cells by intraperitoneal injection with
250 μg of anti-CD4 (α-CD4) monoclonal antibody (mAb)
GK1.5 at 4 and 6 days post-infection (p.i.). Control animals
received the same amount of α-βgalactosidase (α-βgal)
control mAb GL113. Recipients were depleted of CD8 T
cells by intraperitoneal injection with 250 μg of anti-CD8
(α-CD8) mAb 2.43 at day −2, 0, and 7 p.i. These regimens
resulted in more than 99% depletion of CD4 or CD8 T cells
in the periphery and CNS. Control animals received the
same amount of control mAb GL113. Animals were scored
daily for clinical signs of disease on a four-point scale (0 =
healthy; 1 = ruffled fur and hunched back; 2 = hind-limb
paralysis or inability to turn to upright position; 3 =
complete hind-limb paralysis and wasting; 4 = moribund or
dead).
Virus titers and cytokine determination
Virus titers within the brain were determined in clarified
supernatants by plaque assay, using the murine DBT astro-
cytoma cell line as described previously [26]. Plaques were
counted 48 hours after incubation at 37°C. Clarified super-
natants were also used to measure IFN-γ by ELISA as
described [22]. Briefly, 96 well plates were coated overnight
at 4°C with 100 μl of 1 μg/ml of α-IFN-γ (R4-6A2; BD
Biosciences, San Jose, CA, USA). Non-specific binding was
blocked with 10% fetal calf serum in PBS for 1.5 h before
the addition of IFN-γ recombinant cytokine standard (BD
Biosciences) and samples. After a 2 h incubation at room
temperature bound IFN-γ was detected using biotinylated
α-IFN-γ antibody (XMG1.2, BD Biosciences) and avidin
peroxidase followed by 3,30,5,50 tetramethylbenzidine
(TMB Reagent Set; BD Biosciences) 1h later. Optical dens-
ities were read at 450 nm in a microplate reader (Model
680; Bio-Rad Laboratories, Hercules, CA, USA) and ana-
lyzed using Microplate Manager software (version 5.2; Bio-
Rad Laboratories).
Isolation of mononuclear cells
CNS-derived cells were isolated as described previously
[20]. Briefly, brains or spinal cords from PBS-perfused
mice (n = 3 to 6) were homogenized in ice-cold Ten-
broeck tissue grinders in Dulbecco’s PBS. Homogenates
were clarified by centrifugation at 400 g for 7 minutes,
and the supernatants were collected and stored at −80°C
for further analysis. Cell pellets were resuspended in
RPMI supplemented with 25 mmol/l HEPES, adjusted
to 30% Percoll (Pharmacia, Piscataway, NJ, USA) and
underlaid with 1 ml of 70% Percoll. After centrifuga-
tion at 800 g for 30 minutes at 4°C, cells were
recovered from the 30/70% interface, washed once,
and resuspended in fluorescence-activated cell sorting
(FACS) buffer. CNS-derived cell populations for PCR
analysis were isolated from infected mice as described
above. Cell suspensions from cervical lymph nodes
(CLNs) were prepared from identical animals as previ-
ously described [20].
Flow-cytometry analysis and fluorescence-activated cell
sorting
Cells were incubated with mouse serum and rat α-mouse
FcγIII/II mAb for 15 minutes on ice before staining.
Expressionof cell surface markers was determined by incu-
bation of cells with fluorescein isothiocyanate (FITC)-
conjugated, phycoerythrin (PE)-conjugated, Peridinin
Chlorophyll Protein Complex (PerCP) (PerCP)-conjugated,
or allophycocyanin-conjugated mAbs specific for CD45
(30-F11), CD4 (L3T4), CD8 (53–6.7) CD44 (IM7), CD62L
(MEL-14) (all BD Biosciences), PD-1 (RMP1-30;
eBioScience San Diego, CA, USA) and F4/80 (CI:A3-1;
Serotec, Raleigh, NC, USA) for 30 minutes on ice.
Virus-specific CD8 T cells were identified using Db/S510
MHC class I tetramers (Beckman Coulter Inc., Fullerton,
CA, USA) as described previously [20]. Stained cells were
washed twice with FACS buffer and fixed in 2% paraformal-
dehyde. For intracellular detection of granzyme B or IFN-γ,
the cells were stained for cell surface markers be-
fore permeabilization (Cytofix/Cytoperm Reagent; BD
Biosciences) and staining with allophycocyanin-labeled
α-granzyme B Ab (GB12, isotype-control mouse IgG1;
Caltag Laboratories Burlingame, CA, USA) or α-IFN-γ Ab
(BD Biosciences). A minimum of 2 × 105 viable cells were
stained and analyzed on a flow cytometer (FACS Calibur;
BD, Mountain View, CA, USA). Data were analyzed
using FlowJo software (Tree Star Inc., Ashland, OR,
USA). CNS monocyte-derived CD45hiF4/80+ macro-
phages, CD45lo microglia, and CD4 and CD8 T cells
were purified from pooled brains (n = 6 to 8) using a
cell sorter (FACSAria; BD). CD4CD44hiCD62Llo (ef-
fector) and CD4CD44loCD62Lhi (naive) cells were also
purified from pooled CLNs. A minimum of 5 × 104 cells
were collected per pooled sample, and frozen in 400 μl
Trizol reagent (Invitrogen, Carsbad, CA, USA) at −80°C
for subsequent RNA extraction and PCR analysis as
described previously [27].
Virus-specific IFN-γ production by CLN-derived CD8 T
cells was evaluated after peptide stimulation. Briefly, 2 ×
106 CLN cells were cultured in the absence or presence of
1 μmol/l S510 peptide encompassing the H-2Db-restricted
CD8 T-cell epitope in a total volume of 200 μl RPMI sup-
plemented with 10% fetal calf serum for 5h at 37°C with a
protein transport inhibitor (GolgiStop; BD Bioscience) at 1
μl/ml. After stimulation, cells were stained for surface ex-
pression of CD8, CD44, and CD62L, fixed, and then
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permeabilized to detect intracellular IFN-γ as recom-
mended by the supplier (BD Biosciences).
Histopathology
Spinal cords from PBS-perfused mice were fixed in 10%
formalin and embedded in paraffin. In some experiments,
the spinal cords were sectioned longitudinally, while in
others they were cut into six segments from cervical to
lumbar regions, and embedded together in paraffin. Cross-
sections from individual mice were examined at each of
the six levels. Demyelination was determined by staining
5 μm sections with Luxol fast blue (LFB), while axonal in-
tegrity was examined using the α-phosphorylated neurofi-
lament mAb SMI-31 and the α-non-phosphorylated
neurofilament mAb SMI-32 (Covance, Princeton, NJ).
Viral nucleocapsid protein was detected by immunoperoxi-
dase staining using the α-JHMV mouse mAb J.3.3 as the
primary antibody, horse α-mouse as secondary antibody
and 3,30-diaminobenzidine (DAB) as substrate (Vectastain
ABC kit; Vector Laboratories, Burlingame, CA, USA).
Microglia and infiltrating macrophages were identified by
immunoperoxidase staining using α-Mac-3 (BD Bio-
science) as the primary antibody and rabbit α-rat as sec-
ondary antibody. With the exception of the LFB staining,
all sections were counterstained with hematoxylin. Double
immunoperoxidase staining for an oligodendroglial marker
(rabbit α-glutathione S-transferase (α-GST; Enzo Life
Sciences, Farmingdale, NY, USA) and viral antigen (J.3.3
mAb) was performed on paraffin embedded sections after
antigen retrieval (Vector Laboratories);. Immunolabeling
was identified using a commercial kit (Vectastain ABC)
with DAB and Vector SG chromogens, respectively.
Histologic imaging
High-resolution digital images were obtained using a
slide scanner (ScanScope; Aperio, Vista, CA, USA) with
a 20× lens objective and doubling lens. Images were
viewed using ImageScope software (Aperio). For semi-
quantitative analyses, sections were scored in a blinded
fashion, and representative fields were identified based
on the average score of all sections in each experimental
group. For quantitative analyses (for example, Mac-3
and SMI-31 plus SMI-32 immunolocalization) images
were analyzed using the ‘positive pixel count v9’ algo-
rithm (Aperio) to obtain the percentage of positive pixels
in representative fields of 5 mm2.
PCR
RNA was extracted from FACS-purified cell populations
frozen in 400 μl Trizol reagent (Invitrogen) as recom-
mended by the supplier. DNA contamination was
removed by treatment with DNase I (DNA-free kit;
Ambion, Austin, TX, USA) for 30 minutes at 37°C,
and cDNA was synthesized from RNA using reverse
transcriptase (M-MLV; Invitrogen), oligo-dT primers
and random primers (all Promega, Madison, WI, USA).
Quantitative real-time PCR was performed using 4 μl of
cDNA and SYBR Green (SYBR Green Master Mix; Ap-
plied Biosystes, Foster City, CA, USA) in triplicate on a
PCR system (7500 Fast Real-Time PCR System; Applied
Biosystems). PCR conditions were 10 minutes at 95°C
followed by 40 cycles at 95°C for 15 seconds, 60°C for 30
seconds and 72°C for 30 seconds. Previously described
primers were used for transcripts encoding glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH), viral nu-
cleocapsid, interleukin (IL)-10 and IL-21, and inducible
nitric oxide synthase (iNOS) [15,28]. GAPDH, IL-2,
IFN-γ and perforin mRNA levels were determined using
gene expression arrays (Applied Biosystems) with a com-
mercial master mix and primers (Universal Taqman Fast
Master Mix and Taqman primers; both Applied Biosys-
tems). PCR conditions were 20 seconds at 95°C followed
by 40 cycles at 95°C for 3 seconds and 60°C for 30 sec-
onds. Transcript levels were calculated relative to the
housekeeping gene GAPDH using the formula:
2 CT GAPDHð Þ–CT target geneð Þ½   1000;
where CT represents the threshold cycle at which the
fluorescent signal becomes significantly higher than that
of the background.
Statistical analysis
Results are expressed as the mean ± SEM for each group
of mice. In all cases, P<0.05 was considered significant.
Graphs were plotted and statistics assessed using Graph-
Pad Prism software (version 3.0).
Results
B7-H1 deficiency does not compensate for the essential
anti-viral role of CD4 T-cell help
During sub-lethal JHMV infection of WT mice, CD4
T-cell help is required for efficient priming and expan-
sion of virus-specific CD8 T cells in CLNs, and to
support their effector function in the CNS [8]. To assess
whether relief from B7-H1 inhibitory signals overcomes
the local requirement of CD4 T cell help without affect-
ing initial CD8 T cell expansion, CD4 T cell depletion
was delayed until day 4 p.i. in B7-H1−/− mice. Infectious
virus levels were similar at day 7 p.i. in the brains of WT
and B7-H1−/− mice, irrespective of the presence or ab-
sence of CD4 T cells (Figure 1A). Furthermore, the virus
was more effectively controlled in undepleted B7-H1−/−
relative to WT mice, confirming previous results [15,22].
In CD4-depleted WT mice, loss of viral control was evi-
dent at day 10 p.i., but was much more pronounced by
day 14 p.i., relative to undepleted mice. By contrast,
CD4-depleted B7-H1−/− mice already harbored at least
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10-fold more infectious virus at day 10 p.i. compared
with undepleted B7-H1−/− controls, and subsequently
failed to control infectious virus (Figure 1A). Loss of viral
control was thus accelerated in CD4 depleted B7-H1−/−
mice relative to the respective WT groups (Figure 1A).
Nevertheless, relative to CD4-depleted WT mice, viral
titers in CD4-depleted B7-H1−/− mice were significantly
lower at days 10 and 14 p.i., suggesting that unhelped
CD8 T cells are still more functional in B7-H1−/− than in
WT mice. Consistent with the higher viral titers, the
number of virus-infected cells exhibiting glial morph-
ology, predominantly oligodendroglia, was increased in
the spinal-cord white matter of CD4-depleted B7-H1−/−
mice (Figure 1B). Frequent infection of oligodendroglial
cells was confirmed by double immunoperoxidase label-
ing with an oligodendroglial marker (α-GST) and anti-
viral nucleocapsid antibody (J.3.3) (Figure 1C).
Frequencies of IFN-γ-secreting CD8 T cells in the drain-
ing CLNs were not affected by the absence of B7-H1 or
CD4 depletion in either WT or B7-H1−/− mice
(Figure 1D), supporting B7-H1-independent peripheral ex-
pansion [15] and intact peripheral CD4 T-cell help. Flow
cytometry further showed that CD4 T-cell depletion did
not overtly affect CNS cellular inflammation in B7-H1−/−
mice, as the numbers of CD45hi CNS-infiltrating cells, F4/
80-positive macrophages, total CD8 T cells, and virus-
specific CD8 T cells were similar to those in undepleted
B7-H1−/− mice (Figure 2). Failure of virus control was thus
not attributable to impaired peripheral expansion or CNS
accumulation of virus-specific CD8 T cells. These results
are similar to those seen in WT mice depleted of CD4
T cells subsequent to T-cell priming [8], and suggest
that impaired viral control in CD4-depleted B7-H1−/−
mice results from diminished local CD8 T-cell function.
Figure 1 Loss of central nervous system viral control in CD4-depleted B7-H1−/− mice. Infected wild-type (WT) and B7-H1−/− mice were
treated with α-CD4 or control α-βgalactosidase (α-βgal) monoclonal antibody (mAb) at 4 and 6 days post-infection (p.i). (A) Virus titers in the
brain determined by plaque assay expressed as mean ± SEM. Dashed line represents limit of detection. Significant differences between CD4-
depleted and CD4-undepleted mice were determined by the unpaired t-test. * P<0.05 and *** P<0.001, respectively. Significant differences
comparing CD4 depleted WT and B7-H1−/− mice were determined by the unpaired t-test. # P<0.05 and ### P<0.001, respectively. (B) Virus-infected
cells detected in spinal-cord white-matter tracks using α-nucleocapsid mAb (J.3.3; brown) with hematoxylin counterstain at 10 days p.i. (C) Double
immunohistochemical staining with rabbit α-glutathione S-transferase (α-GST) antibody labeling the oligodendrocytes (brown; DAB chromogen)
and α-nucleocapsid J.3.3 mAb (blue/grey SG chromogen). Arrows point to virus-infected oligodendroglial cells (double-labeled), adjacent to non-
infected oligodendroglial cells (labeled with DAB only). Magnification bar = 10 μm. (D) Frequencies of virus-specific interferon (IFN)-γ secreting
CD8 T cells per 106 CD8 T cells in CLNs at day 5 and 7 p.i. detected by flow cytometry after S510 peptide stimulation. Data are representative of
two independent experiments with four mice per time point per experiment.
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Absence of B7-H1 does not rescue anti-viral function of
unhelped CD8 T cells
Virus-specific CD8 T cells derived from the CNS of CD4
T-cell sufficient or depleted B7-H1−/− mice were assayed
directly ex vivo without peptide stimulation for gran-
zyme B expression as a marker for cytolytic capacity. In-
deed, unhelped virus-specific CD8 T cells expressed
lower levels of granzyme B compared with their helped
counterparts at days 7 and 10 p.i. (Figure 3A). IFN-γ
levels were also significantly reduced in the CNS of
CD4-depleted B7-H1−/− mice at day 7 p.i., but were
similar to B7-H1−/− controls by day 10 p.i. (Figure 3B).
Impaired IFN-γ production specifically in CD8 T cells
in vivo was supported by ~2 and 3-fold lower IFN-γ
transcript levels specifically in CD8 T cells purified
from the CNS of CD4-depleted mice relative to control
B7-H1−/− mice at days 7 and 10 p.i., respectively
(Figure 3C). Similarly, transcript levels of perforin were
reduced by around 2-fold (Figure 3C), correlating with
diminished granzyme B expression in CD4-depleted B7-
H1−/− mice (Figure 3A). IL-10 expression was also
assessed, as highly lytic CD8 T cells were recently asso-
ciated with high IL-10 production [29]. IL-10 tran-
scripts were decreased by around 2.5-fold in CD8 T
cells from CD4-depleted B7-H1−/− mice (Figure 3C),
whereas tumor necrosis factor and IL-2 transcripts
remained similar (data not shown), indicating that
decreased function of B7-H1−/− CD8 T cells in absence
of CD4 T cells was not global. Therefore, blockade of
PD-1:B7-H1 inhibitory signaling did not compensate for
the crucial role of CD4 T-cell help in optimizing CD8
T-cell anti-viral function at the effector site.
Figure 2 Similar central nervous system recruitment of leukocytes in CD4 depleted B7-H1−/− mice. B7-H1−/− infected mice were treated
with α-CD4 or control α-βgal monoclonal antibody at 4 and 6 days post-infection (p.i.). CNS-infiltrating cells were analyzed by flow cytometry
from pooled brains. Numbers of (A) total CD45hi CNS-infiltrating cells, (B) CD45hiF4/80+ macrophages, (C) CD8 T cells and (D) virus-specific Db/
S510 tetramer+ CD8 T cells are shown. Data depict the mean ± SEM of two independent experiments with at least three mice per time point per
experiment. Significant differences were determined by the unpaired t-test. * P<0.05 and ** P<0.005. NS = not significant.
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B7-H1 regulates CD4 T-cell function in the CNS
Our original studies in B7-H1−/− mice focused on CD8 T
cells because oligodendrocytes are the major targets of
infection and strongly upregulate B7-H1, coincident with
MHC class I [22]. CD4 T cells were expected to have less
pronounced effects relative to CD8 T cells, as infection of
microglia and macrophages, constituting MHC class II-
expressing APCs, is relatively sparse compared with oli-
godendrocytes [30]. Furthermore, B7-H1 expression is
both modest and transient in microglia [22]. Neverthe-
less, comparable or higher expression of IFN-γ mRNA by
CNS-infiltrating CD4 compared with CD8 T cells at the
population level supported T-cell receptor-driven activity
[15], and thus potential regulation by PD-1:B7-H1. Al-
though less than 10% of CNS-derived CD4 T cells
initially expressed PD-1 at day 5 p.i., this percentage rap-
idly increased to ~60% by day 7 p.i. and ~80% by day 14
p.i. (Figure 4A), showing that the vast majority of CD4 T
cells infiltrating the CNS express PD-1 during control of
the virus. To assess whether PD-1:B7-H1 interactions
alter CD4 function, CD4 T cells were purified by FACS
from the CNS of infected WT and B7-H1−/− mice at day
7 p.i. IFN-γ mRNA levels were around 2-fold higher in
CD4 T cells from B7-H1−/− relative to WT mice
(Figure 4B). Moreover, CD4 T cells from B7-H1−/− mice
had mRNA levels that were around 2.5-fold higher for
IL-21 and 5-fold higher IL-10, compared with WT CD4
T cells (Figure 4B). However, the similar levels of IL-2
mRNA suggested that not all cytokines were affected by
the absence of B7-H1. To assess whether cytokine-
Figure 3 Compromised CD8 effector function in the central nervous system of CD4-depleted B7-H1−/− mice. Infected B7-H1−/− mice were
treated with α-CD4 or control α-βgalactosidase (α-βgal) monoclonal antibody at 4 and 6 days post-infection (p.i) (A) Pooled brain cells (n ≥ 4/
group) isolated at days 7 and 10 p.i. were stained for CD8, Db/S510-specific T-cell receptor and intracellular granzyme B. Representative density
plots gated on CD8 T cells depict α-granzyme B and Db/S510 tetramer staining. Mean fluorescence intensity (MFI) of granzyme B in Db/S510
tetramer+ CD8 T cells is shown in the upper right-hand quadrant. Data are representative of three independent experiments. (B) CNS interferon
(IFN)-γ protein determined by ELISA at the indicated days p.i. Data represent the mean ± SEM (n ≥ 6/group) of two separate experiments.
Significant differences were determined by the unpaired t-test. *** P<0.001. (C) Transcript levels of IFN-γ, perforin and interleukin (IL)-10 in CD8 T
cells purified by fluorescence-activated cell sorting from the pooled brains of n = 6 to 8 mice collected at 7 and 10 days p.i. assessed by PCR.
Transcript levels relative to GAPDH × 1000 are presented as fold change with levels from B7-H1−/− α-βgal day 7 p.i. samples set to 1. Data depict
the mean ± SEM of two independent experiments.
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expression differences were imprinted during priming in
the periphery or acquired within the CNS, activated
CD44hiCD62Llo and naïve CD44loCD62Lhi CD4 T cells
from the CLNs of infected WT and B7-H1−/− mice were
purified by FACS at day 5 p.i. (Figure 5). Cytokine mRNA
levels for IFN-γ, IL-2, IL-10, and IL-21 were either un-
detectable or were below values of 0.1 in CD4 T cells
expressing a naïve CD44loCD62Lhi phenotype (data
not shown). Similar to the CNS, IFN-γ levels in
CD44hiCD62Llo cells were around 3-fold higher in the
absence of B7-H1 at 5 days p.i. A similar trend was ap-
parent for IL-10 mRNA levels, which were increased by
less than 2-fold in B7-H1−/− CD4 T cells. By contrast, B7-
H1 deficiency did not alter mRNA levels of IL-2 or IL-21
in activated CLN-derived CD4 T cells. Of note, IL-21, a
positive regulator of CD8 T cells [31-35], was the only
cytokine that was specifically higher in the CNS-derived
but not in CLN-derived B7-H1−/− CD4 T cells. These
data suggest that PD-1 expression on CD4 T cells during
JHMV infection negatively regulates CD4 T-cell effector
activity both during initial expansion and in the CNS.
Increased CNS effector function of CD8 T cells in
infected B7-H1−/− mice may thus not only be attributed
to directly abrogated B7-H1 signaling, but also to
enhanced local CD4 T cell help.
During the initial phase of JHMV infection, the virus
replicates in both microglia and macrophages [27,30].
Both populations upregulate MHC class I and class II,
and thus constitute targets capable of engaging CD4 and
CD8 T cells within the CNS; astrocytes and oligodendro-
cytes fail to upregulate MHC class II [23,36]. Infected
DCs are difficult to detect in the periphery [37,38] and
Figure 4 B7-H1 negatively regulates CD4 T cell activity in the central nervous system. (A) Representative density plots depicting PD-1
expression on CD4 T cells from spinal cords of infected wild-type (WT) mice at the indicated days post-infection (p.i).; numbers within plots
represent percentage of PD-1-positive CD4 T cells. Data are representative of two independent experiments with three mice per time point. (B)
Interferon (IFN)-γ, interleukin (IL)-2, IL-10, and IL-21 transcripts in purified CD4 T cells from WT or B7-H1−/− brains at 7 days p.i. Transcript levels
relative to GAPDH × 1000 are presented as fold change with levels from WT samples set at 1. Expression levels relative to GAPDH in WT samples
were as follows: IFN-γ = 60; IL-10 = 55; IL-21 = 41; and IL-2 = 1.1. Data depict the mean ± SEM of two independent experiments.
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have not been described within the CNS, to our knowledge.
We therefore compared B7-H1 expression on CNS macro-
phages versus microglia. Microglia upregulated B7-H1 only
modestly at 7 days p.i. (Figure 6A), confirming previous
results [22]. By contrast, around 60% of macrophages
expressed B7-H1 at 7 days p.i. (Figure 6A). Furthermore,
whereas B7-H1 expression was transient on microglia, it
was sustained on the majority of macrophages at day
14 p.i. The absence of B7-H1 on infected macro-
phages may thus directly underlie the enhanced CD4
T-cell effector activity in the CNS. To assess the po-
tential effect of release from B7-H1 inhibition and
CD4 depletion on viral replication in CD45lo micro-
glia and CD45hiF4/80+ macrophages, both cell popu-
lations were isolated from the CNS and analyzed for
expression of viral mRNA. Transcripts encoding the
viral nucleocapsid protein were higher in CD45lo
microglia and CNS CD45hiF4/80+ macrophages iso-
lated from CD4-depleted mice compared with control
B7-H1−/− mice at both day 7 and day 10 p.i. (Figure 6B).
Furthermore, both microglia and macrophages exhibited a
reduction in viral mRNA between days 7 and 10 p.i. in
undepleted mice, whereas only macrophages showed
decreased viral mRNA in CD4 depleted mice between days
7 and 10 p.i.
These data support a contribution of CD4 T cells,
either directly or indirectly, via enhancement of CD8
T-cell effector function in controlling virus in microglia/
macrophages that express MHC class II. To reveal a direct
effect of B7-H1 on CD8 T cells, effector functions in
helped or unhelped CNS-derived B7-H1−/− CD8 T cells
were compared with their respective WT CD8 T-cell
counterparts (Figure 7). In virus-specific CD8 T cells,
the levels of granzyme B were comparable between
unhelped B7-H1−/− and helped WT populations at
days 7 and 10 p.i. (Figure 7A). Moreover, granzyme
B levels in unhelped B7-H1−/− cells were higher than
those in unhelped WT cells, but lower than those in
helped B7-H1−/− cells (Figure 7A). Notably, granzyme
B levels correlated well with differences in viral load
at day 10 p.i., especially in the comparison between WT
mice and CD4-depleted B7-H1−/− mice (Figure 1A). Tran-
script levels of IFN-γ in purified CD8 T cells from the CNS
of CD4-depleted B7-H1−/−were similar to those in
helped WT mice at day 7 p.i., but reduced by 60% at
day 10 p.i. (Figure 7B). Similarly, IL-10 transcripts were
equivalent in unhelped CD8 T cells from B7-H1−/− and
helped WT mice, supporting the notion that IL-10+
CD8 T cells are highly cytotoxic during JHMV infection
[29]. Overall, these results suggest that unhelped ex vivo
CD8 T-cell effector activity in B7-H1−/− mice is compar-
able with helped WT CD8 T cells at day 7 p.i., and is
only slightly diminished at day 10 p.i. Thus, B7-H1
blockade directly increases CD8 T-cell activity, even in
the absence of CD4 T cells. However, the additional help
provided by CD4 T cells in the absence of B7-H1 has
an over-riding influence in both increasing CD8 T-cell
activity early, and in prolonging function.
Figure 5 B7-H1 dampens CD4 T-cell activity during priming. (A-D) Relative transcript levels of (A) interferon (IFN)-γ, (B) interleukin (IL)-10, (C)
IL-2 (D) and IL-21 in CD44hiCD62Llo CD4 T cells purified by fluorescence-activated cell sorting from cervical lymph nodes of wild-type (WT) or B7-
H1−/− mice at 5 days post-infection. Transcript levels are relative to GAPDH × 1000. Data depict the mean ± SEM of two independent
experiments.
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CD4 T cells are mediators of exacerbated disease in
B7-H1−/− mice
JHMV encephalomyelitis in B7-H1−/− mice is associated
with increased morbidity and axonal damage within the
demyelinated lesions compared with WT mice, despite
accelerated virus control [15]. These data were initially
attributed to enhanced CD8 T-cell function mediated by
release from B7-H1 interactions with infected oligoden-
drocytes. However, the absence of more severe demye-
lination posed a conundrum [15]. The present study
Figure 6 Central nervous system-infiltrating macrophages display enhanced B7-H1 expression relative to microglia. (A) B7-H1 expression
on CD45lo microglia and CD45hiF4/80+ macrophages from spinal cords of infected wild-type mice at the indicated days post-infection (p.i). Flow-
cytometry histograms depict B7-H1 expression by solid lines, and isotype-control staining by dashed lines. Numbers represent percentages of B7-H1
positive cells relative to isotype controls. Data are representative of two independent experiments with three to five mice per timepoint. (B) Transcripts
encoding viral nucleocapsid protein in microglia and macrophages purified from CD4-competent or CD4-depleted B7-H1−/− mice (n = 6 to 8) at 7 and
10 days .p.i. Transcript levels are relative to GAPDH × 1000. Data are representative of two independent experiments with similar trends.
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demonstrates that CD4 T cells play a substantial role in
contributing to enhanced IL-21 and IFN-γ production,
which can be detrimental in the CNS [39,40]. Surpris-
ingly, CD4 T-cell depletion in B7-H1−/− mice lowered
the severity of clinical disease substantially, and
increased survival rates from around 30% in control B7-
H1−/− mice to around 80% (Figure 8A,B), despite higher
viral load (Figure 1). Notably CD4-depleted B7-H1−/−
mice displayed slightly reduced clinical symptoms com-
pared with CD4-competent WT mice, despite similar
CD8 T-cell effector function in both groups (Figure 7).
Similar, yet less prominent, results were seen in the
Figure 7 B7-H1 deficiency directly increases CD8 T-cell activity in the absence of CD4 T cells. Infected wild-type (WT) and B7-H1−/− mice
were treated with α-CD4 or control α-βgalactosidase (α-βgal) monoclonal antibody at 4 and 6 days post-infection (p.i).. (A) Mean fluorescence
intensity (MFI) of granzyme B expression by brain-derived virus-specific CD8 T cells (n ≥ 3/group) at days 7 and 10 p.i. Data are representative of
two independent experiments with similar trends. (B,C) Relative transcript levels of (B) interferon (IFN)-γ and (C) interleukin (IL)-10 in CD8 T cells
purified from brain at 7 and 10 days p.i. Transcript levels are relative to GAPDH × 1000. Data are representative of two independent experiments
with similar trends.
Figure 8 CD4 depletion increases survival of B7-H1−/− mice. Infected wild-type (WT) and B7-H1−/− mice treated with α-CD4 or control α-
βgalactosidase (α-βgal) monoclonal antibody (mAb) at 4 and 6 days post-infection (p.i) were monitored for (A) clinical symptoms and (B) survival.
Significant differences in clinical symptoms comparing control and CD4-depleted WT and B7-H1−/− groups, respectively, were determined by
Wilcoxon matched pairs test. ** P<0.005. (C) Clinical symptoms and (D) survival of infected B7-H1−/− mice treated with α-CD8 or control α-βgal
mAb at days −2, 0 and 7p.i.
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comparison of CD4-depleted and control WT mice
(Figure 8B). The extent to which enhanced disease severity
and mortality in B7-H1−/− mice is directly due to increased
CD4 or CD8 T-cell activity is difficult to assess, as CD4 de-
pletion also diminishes CD8 T-cell activity (Figure 7).
However, the similar disease severity in infected WT mice
(harboring helped CD8 T cells), and CD4 T cell-depleted
B7-H1−/− mice (harboring unhelped and uninhibited CD8
T cells), suggests that CD4 T cells primarily exacerbate
CNS injury in B7-H1−/− mice. This notion was supported
by depleting B7-H1−/− mice of CD8 T cells coincident with
JHMV infection. Disease severity and mortality rates were
similar to control B7-H1−/− mice (Figure 8C, D), confirm-
ing CD4 T cells as prominent contributors to clinical dis-
ease during JHMV infection, if not regulated by B7-H1:
PD-1 interactions.
Myelin loss and axonal integrity were assessed to de-
termine whether the ameliorated disease in CD4
depleted B7-H1−/− mice correlated with altered path-
ology. Myelin loss was monitored by LFB staining, while
axonal integrity was assessed by dual staining with mAb
SMI-31, specific for phosphorylated neurofilaments, and
mAb SMI-32, specific for non-phosphorylated neurofila-
ments. Regardless of disease severity, CD4 T cells did
not affect the overall size or number of focal demyelinat-
ing lesions in either WT or B7-H1−/− mice (representa-
tive lesions shown in Figure 9A). Quantitative analysis of
axonal staining (SMI-31 plus SMI-32) showed signifi-
cantly less staining in B7-H1−/− mice (18.1% axonal area)
compared with WT controls (26.1% axonal area) indicat-
ing more axonal loss (P<0.02). B7-H1−/− mice also
exhibited increased numbers of swollen axons within
the demyelinating lesions by qualitative observation
(Figure 9B). Furthermore, the amount of axonal loss and
number of swollen axons within the demyelinated lesion
appeared to be reduced in CD4-depleted mice compared
with their undepleted B7-H1−/− counterparts; however,
the difference in axonal loss did not reach statistical sig-
nificance by quantitative analysis (Figure 9B). A potential
mediator of increased neurotoxicity is IFN-γ-induced
iNOS expression by microglia/macrophages. In CD4-
competent B7-H1−/− mice, enhanced morbidity and
mortality is associated with sustained microglia/macro-
phage iNOS expression [15]. To assess how the decrease
in IFN-γ within the CNS of CD4-depleted B7-H1−/−
mice affects iNOS expression, CD45lo microglia and
CD45hiF4/80+ macrophages were purified and their
iNOS transcript levels compared. Expression of iNOS
mRNA was considerably higher in both microglia and
macrophages from infected CD4 competent B7-H1−/−
mice relative to their WT counterparts, with an increase
of around 3-fold to 4-fold at day 10 p.i. (Figure 10A,B).
Depletion of CD4 T cells in both WT and B7-H1−/− mice
reduced iNOS transcripts, consistent with the decreased
levels of IFN-γ in the CNS (Figure 3). More importantly,
iNOS expression in microglia and macrophages from
CD4-depleted B7-H1−/− mice were similar to those
of the CD4-competent WT counterparts. These data
suggest a correlation between diminished IFN-γ in
CD4-depleted B7-H1−/− mice and reduced microglia/
macrophage activation with decreased axonal damage.
Expression of Mac-3, a marker associated with mye-
loid cell activation, was assessed to further support the
role of IFN-γ in microglia/macrophage activation
(Figure 10C). Although the distribution of cells
expressing Mac-3 within, and adjacent to, spinal-cord
lesions was similar between all groups, differences
were noted in the intensity of staining by qualitative
observation. Therefore, we measured the percentage
of Mac-3+ pixels using Aperio ScanScope software in
multiple spinal-cord regions. Mac-3 staining was more
intense in CD4-competent B7-H1−/− mice (57% image
area) compared with CD4- competent WT mice (43%
image area; P<0.01), and was substantially reduced
after CD4 depletion in both WT (33% image area;
P<0.01) and B7-H1−/−(33% image area; P<0.03) mice
(Figure 10C). These data support the notion that
microglia/macrophage activation correlates with clin-
ical severity.
Discussion
Control of viral CNS infections is dependent on CD8
T-cell effector function in numerous rodent models
[19,41-44]. Because many neurotropic viruses infect
resident cells capable of upregulating MHC class I,
but not class II molecules, effector mechanism are
thought to result from direct target-cell/T-cell inter-
actions. However, CD4 T cells play a supportive role
for CD8 T cells that is less well understood, especially
given the limited MHC class II expression, restricted to
infiltrating APCs and microglia. Making matters more
complex, effector functions by both T-cell subsets are
regulated by inhibitory interactions in a cell type-
specific manner. Specifically, B7-H1 blockade or defi-
ciency enhances or reinvigorates CD8 T-cell function
during prolonged antigen exposure in both visceral tis-
sues and the CNS [3,45-48]. The extent to which po-
tentially exacerbated CD4 T-cell function in the
absence of B7-H1 inhibition influences CD8 T-cell ac-
tivity and viral control is poorly explored. During glia-
tropic JHMV infection, CD8 T cells play a dominant
role in controlling virus replication, but robust IFN-γ-
mediated B7-H1 upregulation on oligodendrocytes, the
prominent target of infection, delays viral control and
contributes to persistence [15,22]. Accelerated viral
control in the absence of B7-H1 thus provides a model
to test whether CD4 T-cell help promoting CD8 T-cell
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Figure 9 Central nervous system pathology in CD4-depleted mice. (A) Spinal cords at day 10 post-infection (p.i). stained with Luxol fast blue
LFB (to identify areas of myelin loss) in wild-type (WT) and B7-H1−/− mice show similar extent of demyelination after treatment with α-CD4 or
control α-βgalactosidase (α-βgal) monoclonal antibody (mAb). Magnification bar = 100 μm. (B) Axonal integrity within demyelinated lesions
visualized with α-SMI-31 plus α-SMI-32 Ab. Demyelinating lesions showed more extensive axonal damage in B7-H1−/− mice, with larger areas of
axonal loss (dotted outline) and increased numbers of swollen axons (arrows). After α-CD4 mAb treatment, lesions appeared to have reduced
axonal loss and decreased numbers of swollen axons. Magnification bar = 100 μm.
Figure 10 Absence of CD4 T cells reduces microglia/macrophage activation. Wild-type (WT) and B7-H1−/− mice were treated with α-CD4 or
control α-βgalactosidase (α-βgal) monoclonal antibody. (A,B) Fluorescence-activated cell sorting-purified CD45lo microglia and CD45hiF4/80+
macrophages from pooled brains (n = 6 to 8) were assessed for transcript levels of inducible nitric oxide synthase (iNOS) relative to GAPDH ×
1000 at 10 days post-infection (p.i). Transcript levels are presented as the fold change relative to levels from WT samples set to 1. Data depict the
mean ± SEM of two independent experiments. (C) Microglia/macrophage activation assessed at day 10 p.i. by Mac-3 staining of spinal cords from
WT (upper panels) and B7-H1−/− (lower panels) mice that were depleted or sufficient in CD4 T cells.
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activity in the CNS of WT mice is also a driving force
for enhanced CD8 T cell activity in B7-H1−/− mice.
The results clearly indicate that CD4 T cells are crucial
in promoting the enhanced anti-viral CD8 T-cell response
in B7-H1−/− mice. Despite reduced CNS chemokine ex-
pression, likely resulting from reduced IFN-γ (data not
shown), the absence of CD4 T cells did not affect initial
CNS accumulation of CD8 T cells in B7-H1−/− mice,
similar to WT mice [8]. Reduced expression of perforin
and IFN-γ transcripts and granzyme B by CNS-derived
B7-H1−/− unhelped CD8 T cells coincided with loss of
CNS viral control at day 10 p.i. The sustained viral loads
are likely responsible for the increased CNS numbers of
total CD8 T cells at day 14 p.i. relative to control mice.
Nevertheless, CD4-depleted B7-H1−/− mice harbored at
least 10-fold lower viral titers at days 10 and 14 p.i. relative
to CD4-depleted WT mice, supporting higher activity of
B7-H1−/− CD8 T cells compared with WT CD8 T cells, re-
gardless of CD4 help. This was substantiated by higher
granzyme B levels in unhelped B7-H1−/− CD8 T cells rela-
tive to unhelped WT CD8 T cells, and provides evidence
that B7-H1 deficiency also directly contributed to
enhanced CNS CD8 T-cell activity in the absence of CD4
T cells.
A direct inhibitory effect of B7-H1 engagement by CD4
T cells was suggested by the high expression of PD-1 on
CNS-infiltrating CD4 T cells during JHMV infection in
WT mice. B7-H1 mediated inhibition was indeed sup-
ported by increased IFN-γ, IL-21 and IL-10 transcript
levels in CNS-derived B7-H1−/− CD4 T cells relative to
their WT counterparts. Increased CD4 T cell activity in the
CNS of B7-H1−/− mice has also been reported in the ex-
perimental allergic encephalomyelitis (EAE) model [49]
and may indirectly contribute to increased anti-viral CD8
T-cell activity in the absence of B7-H1 in the CNS. Al-
though increased IFN-γ and IL-10 mRNA in B7-H1−/−
relative to WT CD4 T cells was already imprinted during
priming in CLNs, enhanced local CNS restimulation was
supported by the specific increase of IL-21 transcripts and
the overall 5-fold to 10-fold higher IFN-γ and IL-10 tran-
script levels in the CNS relative to CLN-derived B7-H1−/−
CD4 T-cell populations. Potential APCs which mediate
B7-H1 suppressors of CD4 T cells within the JHMV-
infected CNS are MHC class II positive macrophages,
based on their strong B7-H1 expression compared with
the modest and transient expression on microglia [22]. Al-
though only few microglia/macrophages are infected, re-
cent evidence demonstrates that CD4 T cells require only a
few MHC class II-presenting cells to elicit IFN-γ secretion
and long-range responsiveness in vivo [50]. However, al-
though direct in vivo evidence for DC infection has been
elusive, it cannot be excluded that viral antigen cross-
presentation by DCs contributes to enhanced B7-H1−/−
CD4 T-cell effector function in the CNS. DCs presumably
initiate T-cell priming within the CLNs, and the absence of
constitutive B7-H1 expression on these APCs gives rise to
enhanced activation of CLN-derived B7-H1−/− CD4 T cells.
Expression of IFN-γ and IL-10 mRNA was also greater in
CLN-derived B7-H1−/− CD8 T cells compared with their
WT counterparts, although these differences were not
reflected in the expansion of virus-specific CD8 T cells
(data not shown). Overall, these results support early
imprinting of B7-H1 on both CD8 and CD4 T-cell function
during priming, which are further amplified by T cell resti-
mulation within the CNS.
In addition to revealing a pronounced direct effect of
B7-H1 on dampening CD4 T-cell activity, CD4 T-cell
depletion indicated these lymphocytes as primary media-
tors of exacerbated disease in B7-H1−/− mice, independ-
ent of increased viral load. This was supported by the
inability of CD8 T-cell depletion to ameliorate disease in
B7-H1−/− mice. The implication that CD8 T cells alone
might be candidates causing exacerbated disease ,based
on more rapid viral control in B7-H1−/− oligodendro-
cytes [15], which express MHC class I, but not class II,
was thus not sustainable. Furthermore, whereas CD4 de-
pletion in B7-H1−/− mice ameliorated disease, despite
impairing viral control, improvement of axonal damage
did not reach statistical significance. These data, com-
bined with similar demyelination, suggested additional
affects of over-activated CD4 T cells on neuronal func-
tion, not necessarily reflected in histological readouts of
neuronal integrity. Nevertheless, preservation of neuro-
logical function also correlates with axon sparing, re-
gardless of demyelination during infection with Theiler’s
murine encephalomyelitis virus [51,52]. The mechanisms
underlying neuronal damage may be to due to misdir-
ected T-cell activity or to secondary bystander effects.
The absence of enhanced neuronal infection in CD4-
competent B7-H1−/− mice excluded a direct virus-
mediated effect. Significantly decreased IFN-γ, reduced
iNOS mRNA expression, and reduced Mac-3 reactivity
in the CNS of CD4-depleted B7-H1−/− mice supports a
direct contribution of CD4-mediated microglia/macro-
phage activation to disease severity and mortality. Al-
though macrophages can mediate demyelination in the
absence of T cells during JHMV infection [53], apparent
preservation of axonal integrity under these conditions
suggests that CD4-mediated activation of the macro-
phages promotes axonal dysfunction. Involvement of
blood-derived infiltrating macrophages in JHMV patho-
genesis is also supported by decreased clinical severity in
CCL2−/− mice [54]. Similarly, inhibition of macrophage
function in other experimental CNS diseases, such as
EAE and encephalomyelitis caused by Theiler’s murine
encephalomyelitis virus, ameliorates disease [55-57]. A
contribution of iNOS as a detrimental effector molecule
is consistent with the association between increased
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levels of iNOS expression and the pathological changes
in other CNS disorders such as multiple sclerosis and its
animal correlate EAE [58-62]. iNOS synthesizes the free
radical nitric oxide (NO), which is implicated in patho-
logic processes due to its cytotoxicity at high concentra-
tions and the destructive molecules generated from NO
such as peroxynitrite [63-66] . Although iNOS does not
seem to contribute directly to JHMV pathogenesis [67],
it cannot be excluded that increased levels of NO or its
products in B7-H1−/− mice have deleterious local effects
in the CNS.
Conclusions
This study demonstrates that CD4 T-cell helper func-
tions contribute significantly to enhanced CD8 T-cell ac-
tivity in B7-H1−/− mice, in addition to the direct relief of
CD8 T cells from PD-1:B7-H1 inhibitory signaling within
the CNS. PD-1:B7-H1 blockade is thus insufficient to
overcome CD4 T cell helper function to CD8 T cells dur-
ing JHMV infection. Moreover, CD4 T cells are promin-
ent contributors to bystander pathology during JHMV
infection if not regulated by B7-H1:PD-1 interactions.
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